GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shockwave Medical Inc (STU:36M) » Definitions » EBITDA Margin %

Shockwave Medical (STU:36M) EBITDA Margin % : 25.62% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shockwave Medical EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Shockwave Medical's EBITDA for the three months ended in Mar. 2024 was €51.6 Mil. Shockwave Medical's Revenue for the three months ended in Mar. 2024 was €201.3 Mil. Therefore, Shockwave Medical's EBITDA margin for the quarter that ended in Mar. 2024 was 25.62%.


Shockwave Medical EBITDA Margin % Historical Data

The historical data trend for Shockwave Medical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shockwave Medical EBITDA Margin % Chart

Shockwave Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial -111.40 -92.26 -1.75 26.05 26.23

Shockwave Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.75 20.19 27.20 30.29 25.62

Competitive Comparison of Shockwave Medical's EBITDA Margin %

For the Medical Devices subindustry, Shockwave Medical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shockwave Medical's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shockwave Medical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Shockwave Medical's EBITDA Margin % falls into.



Shockwave Medical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Shockwave Medical's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=175.646/669.621
=26.23 %

Shockwave Medical's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=51.567/201.301
=25.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shockwave Medical  (STU:36M) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Shockwave Medical EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Shockwave Medical's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shockwave Medical (STU:36M) Business Description

Traded in Other Exchanges
Address
5403 Betsy Ross Drive, Santa Clara, CA, USA, 95054
ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries.

Shockwave Medical (STU:36M) Headlines

No Headlines